loadpatents
name:-0.011003017425537
name:-0.0029950141906738
name:-0.00056791305541992
Gianella-Borradori; Athos Patent Filings

Gianella-Borradori; Athos

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gianella-Borradori; Athos.The latest application filed is for "purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases".

Company Profile
0.3.9
  • Gianella-Borradori; Athos - Gauting N/A DE
  • Gianella-Borradori, Athos - Dundee GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases
Grant 8,809,350 - Benigni , et al. August 19, 2
2014-08-19
Purine And Pyrimidine Cdk Inhibitors And Their Use For The Treatment Of Autoimmune Diseases
App 20120309723 - BENIGNI; Ariela ;   et al.
2012-12-06
Methods of treatment using sapacitabine
Grant 8,124,593 - Gianella-Borradori , et al. February 28, 2
2012-02-28
Methods of Treatment Using Sapacitabine
App 20090118315 - Gianella-Borradori; Athos ;   et al.
2009-05-07
Purine and Pyrimidine Cdk Inhitbitors and Their use for The Treatment of Autoimmune Diseases
App 20080125404 - Benigni; Ariela ;   et al.
2008-05-29
Combination comprising a CDK inhibitor and a topoisomerase 1 inhibitor for the treatment of cancer and other proliferative diseases
App 20060148828 - Gianella-Borradori; Athos ;   et al.
2006-07-06
Combination comprising a CDK inhibitor and cisplatin
App 20050276866 - Gianella-Borradori, Athos
2005-12-15
Combination comprising docetaxel and a CDK inhibitor
App 20050277656 - Gianella-Borradori, Athos
2005-12-15
Pharmaceutical composition comprising a CDK inhibitor and gemcitabine
App 20050267066 - Gianella-Borradori, Athos
2005-12-01
Combination of a CDK inhibitor and mitoxantrone
App 20050261260 - Gianella-Borradori, Athos
2005-11-24
Methods of treatment of chronic lymphocytic leukemia using roscovitine
App 20050153991 - Gianella-Borradori, Athos ;   et al.
2005-07-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed